MR guided focused ultrasound

Technical acceptance measures for a clinical system

K. R. Gorny, N. J. Hangiandreou, G. K. Hesley, B. S. Gostout, Kiaran Patrick McGee, J. P. Felmlee

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Magnetic resonance (MR) guided focused ultrasound (MRgFUS) is a hybrid technique which offers efficient and safe focused ultrasound (FUS) treatments of uterine fibroids under MR guidance and monitoring. As a therapy device, MRgFUS requires systematic testing over a wide range of operational parameters prior to use in the clinical environment. We present technical acceptance tests and data for the first clinical MRgFUS system, ExAblate® 2000 (InSightec Inc., Haifa, Israel), that has been FDA approved for treating uterine fibroids. These tests characterize MRgFUS by employing MR temperature measurements in tissue mimicking phantoms. The coronal scan plane is empirically demonstrated to be most reliable for measuring temperature elevations resulting from high intensity ultrasound (US) pulses ('sonications') and shows high sensitivity to changes in sonication parameters. Temperatures measured in the coronal plane were used as a measure of US energy deposited within the focal spot for a range of sonication parameters used in clinical treatments: spot type, spot length, output power, sonication duration, US frequency, and depth of sonication. In addition, MR images acquired during sonications were used to measure effective diameters and lengths of available sonication spot types and lengths. At a constant 60 W output power, the effective spot type diameters were measured to vary between 4.7 ± 0.3 mm and 6.6 ± 0.4 mm; treatment temperatures were found to decrease with increasing spot diameter. Prescribing different spot lengths was found to have no effect on the measured length or on measured temperatures. Tests of MRgFUS positioning accuracy determined errors in the direction parallel to the propagation of the US beam to be significantly greater than those in the perpendicular direction; most sonication spots were erroneously positioned towards the FUS transducer. The tests reported here have been demonstrated to be sufficiently sensitive to detect water leakage inside the FUS transducer. The data presented could be used for comparison by those conducting acceptance tests on other clinical MRgFUS systems.

Original languageEnglish (US)
Pages (from-to)3155-3173
Number of pages19
JournalPhysics in Medicine and Biology
Volume51
Issue number12
DOIs
StatePublished - Jun 21 2006

Fingerprint

Sonication
Magnetic resonance
acceptability
magnetic resonance
Magnetic Resonance Spectroscopy
Ultrasonics
Temperature
transducers
Leiomyoma
Transducers
Israel
temperature
Acceptance tests
output
positioning
temperature measurement
therapy
leakage
conduction
propagation

ASJC Scopus subject areas

  • Biomedical Engineering
  • Physics and Astronomy (miscellaneous)
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Gorny, K. R., Hangiandreou, N. J., Hesley, G. K., Gostout, B. S., McGee, K. P., & Felmlee, J. P. (2006). MR guided focused ultrasound: Technical acceptance measures for a clinical system. Physics in Medicine and Biology, 51(12), 3155-3173. https://doi.org/10.1088/0031-9155/51/12/011

MR guided focused ultrasound : Technical acceptance measures for a clinical system. / Gorny, K. R.; Hangiandreou, N. J.; Hesley, G. K.; Gostout, B. S.; McGee, Kiaran Patrick; Felmlee, J. P.

In: Physics in Medicine and Biology, Vol. 51, No. 12, 21.06.2006, p. 3155-3173.

Research output: Contribution to journalArticle

Gorny, KR, Hangiandreou, NJ, Hesley, GK, Gostout, BS, McGee, KP & Felmlee, JP 2006, 'MR guided focused ultrasound: Technical acceptance measures for a clinical system', Physics in Medicine and Biology, vol. 51, no. 12, pp. 3155-3173. https://doi.org/10.1088/0031-9155/51/12/011
Gorny, K. R. ; Hangiandreou, N. J. ; Hesley, G. K. ; Gostout, B. S. ; McGee, Kiaran Patrick ; Felmlee, J. P. / MR guided focused ultrasound : Technical acceptance measures for a clinical system. In: Physics in Medicine and Biology. 2006 ; Vol. 51, No. 12. pp. 3155-3173.
@article{8a93d33b24674e3c9d10d4c01b2976ce,
title = "MR guided focused ultrasound: Technical acceptance measures for a clinical system",
abstract = "Magnetic resonance (MR) guided focused ultrasound (MRgFUS) is a hybrid technique which offers efficient and safe focused ultrasound (FUS) treatments of uterine fibroids under MR guidance and monitoring. As a therapy device, MRgFUS requires systematic testing over a wide range of operational parameters prior to use in the clinical environment. We present technical acceptance tests and data for the first clinical MRgFUS system, ExAblate{\circledR} 2000 (InSightec Inc., Haifa, Israel), that has been FDA approved for treating uterine fibroids. These tests characterize MRgFUS by employing MR temperature measurements in tissue mimicking phantoms. The coronal scan plane is empirically demonstrated to be most reliable for measuring temperature elevations resulting from high intensity ultrasound (US) pulses ('sonications') and shows high sensitivity to changes in sonication parameters. Temperatures measured in the coronal plane were used as a measure of US energy deposited within the focal spot for a range of sonication parameters used in clinical treatments: spot type, spot length, output power, sonication duration, US frequency, and depth of sonication. In addition, MR images acquired during sonications were used to measure effective diameters and lengths of available sonication spot types and lengths. At a constant 60 W output power, the effective spot type diameters were measured to vary between 4.7 ± 0.3 mm and 6.6 ± 0.4 mm; treatment temperatures were found to decrease with increasing spot diameter. Prescribing different spot lengths was found to have no effect on the measured length or on measured temperatures. Tests of MRgFUS positioning accuracy determined errors in the direction parallel to the propagation of the US beam to be significantly greater than those in the perpendicular direction; most sonication spots were erroneously positioned towards the FUS transducer. The tests reported here have been demonstrated to be sufficiently sensitive to detect water leakage inside the FUS transducer. The data presented could be used for comparison by those conducting acceptance tests on other clinical MRgFUS systems.",
author = "Gorny, {K. R.} and Hangiandreou, {N. J.} and Hesley, {G. K.} and Gostout, {B. S.} and McGee, {Kiaran Patrick} and Felmlee, {J. P.}",
year = "2006",
month = "6",
day = "21",
doi = "10.1088/0031-9155/51/12/011",
language = "English (US)",
volume = "51",
pages = "3155--3173",
journal = "Physics in Medicine and Biology",
issn = "0031-9155",
publisher = "IOP Publishing Ltd.",
number = "12",

}

TY - JOUR

T1 - MR guided focused ultrasound

T2 - Technical acceptance measures for a clinical system

AU - Gorny, K. R.

AU - Hangiandreou, N. J.

AU - Hesley, G. K.

AU - Gostout, B. S.

AU - McGee, Kiaran Patrick

AU - Felmlee, J. P.

PY - 2006/6/21

Y1 - 2006/6/21

N2 - Magnetic resonance (MR) guided focused ultrasound (MRgFUS) is a hybrid technique which offers efficient and safe focused ultrasound (FUS) treatments of uterine fibroids under MR guidance and monitoring. As a therapy device, MRgFUS requires systematic testing over a wide range of operational parameters prior to use in the clinical environment. We present technical acceptance tests and data for the first clinical MRgFUS system, ExAblate® 2000 (InSightec Inc., Haifa, Israel), that has been FDA approved for treating uterine fibroids. These tests characterize MRgFUS by employing MR temperature measurements in tissue mimicking phantoms. The coronal scan plane is empirically demonstrated to be most reliable for measuring temperature elevations resulting from high intensity ultrasound (US) pulses ('sonications') and shows high sensitivity to changes in sonication parameters. Temperatures measured in the coronal plane were used as a measure of US energy deposited within the focal spot for a range of sonication parameters used in clinical treatments: spot type, spot length, output power, sonication duration, US frequency, and depth of sonication. In addition, MR images acquired during sonications were used to measure effective diameters and lengths of available sonication spot types and lengths. At a constant 60 W output power, the effective spot type diameters were measured to vary between 4.7 ± 0.3 mm and 6.6 ± 0.4 mm; treatment temperatures were found to decrease with increasing spot diameter. Prescribing different spot lengths was found to have no effect on the measured length or on measured temperatures. Tests of MRgFUS positioning accuracy determined errors in the direction parallel to the propagation of the US beam to be significantly greater than those in the perpendicular direction; most sonication spots were erroneously positioned towards the FUS transducer. The tests reported here have been demonstrated to be sufficiently sensitive to detect water leakage inside the FUS transducer. The data presented could be used for comparison by those conducting acceptance tests on other clinical MRgFUS systems.

AB - Magnetic resonance (MR) guided focused ultrasound (MRgFUS) is a hybrid technique which offers efficient and safe focused ultrasound (FUS) treatments of uterine fibroids under MR guidance and monitoring. As a therapy device, MRgFUS requires systematic testing over a wide range of operational parameters prior to use in the clinical environment. We present technical acceptance tests and data for the first clinical MRgFUS system, ExAblate® 2000 (InSightec Inc., Haifa, Israel), that has been FDA approved for treating uterine fibroids. These tests characterize MRgFUS by employing MR temperature measurements in tissue mimicking phantoms. The coronal scan plane is empirically demonstrated to be most reliable for measuring temperature elevations resulting from high intensity ultrasound (US) pulses ('sonications') and shows high sensitivity to changes in sonication parameters. Temperatures measured in the coronal plane were used as a measure of US energy deposited within the focal spot for a range of sonication parameters used in clinical treatments: spot type, spot length, output power, sonication duration, US frequency, and depth of sonication. In addition, MR images acquired during sonications were used to measure effective diameters and lengths of available sonication spot types and lengths. At a constant 60 W output power, the effective spot type diameters were measured to vary between 4.7 ± 0.3 mm and 6.6 ± 0.4 mm; treatment temperatures were found to decrease with increasing spot diameter. Prescribing different spot lengths was found to have no effect on the measured length or on measured temperatures. Tests of MRgFUS positioning accuracy determined errors in the direction parallel to the propagation of the US beam to be significantly greater than those in the perpendicular direction; most sonication spots were erroneously positioned towards the FUS transducer. The tests reported here have been demonstrated to be sufficiently sensitive to detect water leakage inside the FUS transducer. The data presented could be used for comparison by those conducting acceptance tests on other clinical MRgFUS systems.

UR - http://www.scopus.com/inward/record.url?scp=33745070659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745070659&partnerID=8YFLogxK

U2 - 10.1088/0031-9155/51/12/011

DO - 10.1088/0031-9155/51/12/011

M3 - Article

VL - 51

SP - 3155

EP - 3173

JO - Physics in Medicine and Biology

JF - Physics in Medicine and Biology

SN - 0031-9155

IS - 12

ER -